Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
Manufacturing ServicesCatalent and Galapagos Collaborate to Enhance Decentralized CAR-T Manufacturing
4 min read • 2 years ago -
-
-
Discovery & DevelopmentOphthalmic Gel Shows Promising Results for Geographic Atrophy Treatment
4 min read • 2 years ago -
-
Funding & InvestmentsRentschler Biopharma Realigns Strategy to Focus on Biologics
4 min read • 2 years ago -
-
-
Drug Delivery & PackagingFujifilm Diosynth’s USD 8 Billion Expansion Set to Peak in 2025
4 min read • 2 years ago -
-
Discovery & DevelopmentIs North America’s Hold on the Biologics CDMO Market at Risk?
4 min read • 2 years ago -
Discovery & DevelopmentIn Developing Oral Treatments, Complexity is the New Normal
4 min read • 2 years ago
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.







